Immuneering Corporation (IMRX)
NASDAQ: IMRX · USD
$4.23
+0.18 (+4.3%)· Recorded snapshot
Coverage state: Market snapshot only — no published research
Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.
On-demand research
Generate the first IMRX analysis
Start the full research workflow when this ticker is ready in our data system.
| Market cap | 273.7M | |
|---|---|---|
| Net income (ttm) | -54.4M | |
| EPS (ttm) | -$1.06 | |
| Shares out | 64.7M | |
| Volume | 510,070 | |
| Beta | 0.41 | |
| Price target | $18.9 | +345.9% |
Market data
Price
Recent price action with selectable time range.
Financial snapshot
- Net income (ttm)
- -54.4M
- EPS (ttm)
- -$1.06
- Market cap
- 273.7M
Fair-value bridge
- Current price
- $4.23
Analyst consensus
Recommendation
Strong Buy
Price target
$18.9
+345.9%
In the news
Latest news · IMRX
Recent company headlines from major financial publishers.
Valuation
- Market cap
- 273.7M
- P/B
- 1.3x
Profitability
- ROE
- -43.8%
- ROA
- -27.9%
- ROIC
- -28.9%
Balance sheet
- Debt / equity
- 0.02
- Current ratio
- 32.45
- Quick ratio
- 31.50
Trading
- Beta
- 0.41
- Volume
- 510,070
- Dividend yield
- 0.0%